Cargando…

Novel protein biomarkers for pneumonia and acute exacerbations in COPD: a pilot study

INTRODUCTION: Community-acquired pneumonia (CAP) and acute exacerbations of chronic obstructive pulmonary disease (AECOPD) result in high morbidity, mortality, and socio-economic burden. The usage of easily accessible biomarkers informing on disease entity, severity, prognosis, and pathophysiologica...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jung, Anna Lena, Han, Maria, Griss, Kathrin, Bertrams, Wilhelm, Nell, Christoph, Greulich, Timm, Klemmer, Andreas, Pott, Hendrik, Heider, Dominik, Vogelmeier, Claus F., Hippenstiel, Stefan, Suttorp, Norbert, Schmeck, Bernd
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10277477/ https://www.ncbi.nlm.nih.gov/pubmed/37342494 http://dx.doi.org/10.3389/fmed.2023.1180746

Ejemplares similares

Transcriptional analysis identifies potential biomarkers and molecular regulators in pneumonia and COPD exacerbation
por: Bertrams, Wilhelm, et al.
Publicado: (2020)

Surface proteome of plasma extracellular vesicles as mechanistic and clinical biomarkers for malaria
por: Jung, Anna Lena, et al.
Publicado: (2023)

Benefits of whole body vibration training in patients hospitalised for COPD exacerbations - a randomized clinical trial
por: Greulich, Timm, et al.
Publicado: (2014)

High eosinophil blood counts are associated with a shorter length of hospital stay in exacerbated COPD patients – a retrospective analysis
por: Greulich, Timm, et al.
Publicado: (2020)

Lung epithelium as a sentinel and effector system in pneumonia – molecular mechanisms of pathogen recognition and signal transduction
por: Hippenstiel, Stefan, et al.
Publicado: (2006)

The Distribution of Alpha-1 Antitrypsin Genotypes Between Patients with COPD/Emphysema, Asthma and Bronchiectasis
por: Veith, Martina, et al.
Publicado: (2020)

Exacerbations of COPD
por: Viniol, Christian, et al.
Publicado: (2018)

Validity and Usability of Physical Activity Monitoring in Patients with Chronic Obstructive Pulmonary Disease (COPD)
por: Boeselt, Tobias, et al.
Publicado: (2016)

Pneumonie und COVID-19 bei COPD-Patienten
por: Steuder, Regina, et al.
Publicado: (2021)

Real world evaluation of a novel lateral flow assay (AlphaKit® QuickScreen) for the detection of alpha-1-antitrypsin deficiency
por: Greulich, Timm, et al.
Publicado: (2018)

Characterisation of exacerbation risk and exacerbator phenotypes in the POET-COPD trial
por: Beeh, Kai M, et al.
Publicado: (2013)

Bedeutung der Genetik für die Pneumonie und COVID-19
por: Bertrams, Wilhelm, et al.
Publicado: (2021)

Therapy with Plasma Purified Alpha1-Antitrypsin (Prolastin(®)) Induces Time-Dependent Changes in Plasma Levels of MMP-9 and MPO
por: Koepke, Janine, et al.
Publicado: (2015)

A randomized clinical trial to assess the influence of a three months training program (Gym-based individualized vs. Calisthenics-based non-invidualized) in COPD-patients
por: Greulich, Timm, et al.
Publicado: (2014)

Genetik von Lungenkrankheiten
por: Vogelmeier, Claus, et al.
Publicado: (2021)

Transcriptomic comparison of primary human lung cells with lung tissue samples and the human A549 lung cell line highlights cell type specific responses during infections with influenza A virus
por: Bertrams, Wilhelm, et al.
Publicado: (2022)

Systems Medicine for Lung Diseases: Phenotypes and Precision Medicine in Cancer, Infection, and Allergy
por: Schmeck, Bernd, et al.
Publicado: (2015)

Streptococcus pneumoniae induced c-Jun-N-terminal kinase- and AP-1 -dependent IL-8 release by lung epithelial BEAS-2B cells
por: Schmeck, Bernd, et al.
Publicado: (2006)

Tiotropium and Salmeterol in COPD Patients at Risk of Exacerbations: A Post Hoc Analysis from POET-COPD(®)
por: Vogelmeier, Claus F., et al.
Publicado: (2015)

A GATA3-specific DNAzyme attenuates sputum eosinophilia in eosinophilic COPD patients: a feasibility randomized clinical trial
por: Greulich, Timm, et al.
Publicado: (2018)

Legionella pneumophila-Derived Outer Membrane Vesicles Promote Bacterial Replication in Macrophages
por: Jung, Anna Lena, et al.
Publicado: (2016)

Legionella pneumophila Outer Membrane Vesicles: Isolation and Analysis of Their Pro-inflammatory Potential on Macrophages
por: Jung, Anna Lena, et al.
Publicado: (2017)

In ‘real world’ patients with COPD, exacerbation history, and not blood eosinophils, is the most reliable predictor of future exacerbations
por: Worth, Heinrich, et al.
Publicado: (2023)

Rac1 Regulates the NLRP3 Inflammasome Which Mediates IL-1beta Production in Chlamydophila pneumoniae Infected Human Mononuclear Cells
por: Eitel, Julia, et al.
Publicado: (2012)

Patients’ acceptance of outcome and experience measurements during hospitalisation for COPD exacerbations: a CICERO Clinical Research Collaboration–European Lung Foundation online patient survey
por: Gyselinck, Iwein, et al.
Publicado: (2023)

COPD Exacerbation History and Impact on Future Exacerbations – 8-Year Retrospective Observational Database Cohort Study from Germany
por: Vogelmeier, Claus F, et al.
Publicado: (2021)

Diagnosing Alpha-1-Antitrypsin Deficiency Using A PCR/Luminescence-Based Technology
por: Veith, Martina, et al.
Publicado: (2019)

microRNA-125a-3p is regulated by MyD88 in Legionella pneumophila infection and targets NTAN1
por: Jentho, Elisa, et al.
Publicado: (2017)

Cardiovascular predictors of mortality and exacerbations in patients with COPD
por: Alter, Peter, et al.
Publicado: (2022)

Results from a large targeted screening program for alpha-1-antitrypsin deficiency: 2003 - 2015
por: Greulich, Timm, et al.
Publicado: (2016)

THP-1-derived macrophages render lung epithelial cells hypo-responsive to Legionella pneumophila – a systems biology study
por: Schulz, Christine, et al.
Publicado: (2017)

Inhaled corticosteroid use by exacerbations and eosinophils: a real-world COPD population
por: Vestbo, Jørgen, et al.
Publicado: (2019)

COPD Assessment Test Changes from Baseline Correlate with COPD Exacerbations: A Longitudinal Analysis of the DACCORD Observational Study
por: Kardos, Peter, et al.
Publicado: (2020)

Legionella pneumophila infection activates bystander cells differentially by bacterial and host cell vesicles
por: Jung, Anna Lena, et al.
Publicado: (2017)

Longitudinal stability of blood eosinophil count strata in the COPD COSYCONET cohort
por: Greulich, Timm, et al.
Publicado: (2018)

Legionella pneumophila induces human beta Defensin-3 in pulmonary cells
por: Scharf, Stefanie, et al.
Publicado: (2010)

Evaluation of exacerbations and blood eosinophils in UK and US COPD populations
por: Vogelmeier, Claus F., et al.
Publicado: (2019)

IgE is associated with exacerbations and lung function decline in COPD
por: Lommatzsch, Marek, et al.
Publicado: (2022)

Case-finding for alpha1-antitrypsin deficiency in Kazakh patients with COPD
por: Zhumagaliyeva, Ardak, et al.
Publicado: (2017)

Treatment response in COPD: does FEV(1) say it all? A post hoc analysis of the CRYSTAL study
por: Kostikas, Konstantinos, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_14jb2ah8i63j9ljgm3qgb55fd1